| Bioactivity | Denagliptin (GSK823093) is a small molecule dipeptidyl peptidase IV (DPP-4) inhibitor with activity for the suppression of endocrine and metabolic diseases. Denagliptin can be used to study type 2 diabetes. Denagliptin is stable in the solid state but degrades in solution and in mixtures with various excipients. Denagliptin also exhibits degradation in capsules, mainly through cyclization reactions to form (3S,7S,8aS) aminoamines to provide further synthetic materials. The degradation pathway of Denagliptin was elucidated, providing data to support its formulation development and regulatory filings[1]. |
| CAS | 483369-58-0 |
| Formula | C20H18F3N3O |
| Molar Mass | 373.37 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Elucidating the pathways of degradation of denagliptin |
Denagliptin
CAS: 483369-58-0 F: C20H18F3N3O W: 373.37
Denagliptin (GSK823093) is a small molecule dipeptidyl peptidase IV (DPP-4) inhibitor with activity for the suppression
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.